BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of artificial intelligence solutions in neuroscience and immuno-oncology. It also focuses on utilizing technology and research to develop therapeutics solutions. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
37
Frequently Asked Questions
What is Market Cap of BioXcel Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. BioXcel Therapeutics Inc market cap is $51.47M.
What is the 52-week high for BioXcel Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. BioXcel Therapeutics Inc 52 week high is $13.28 as of October 01, 2025.
What is the 52-week low for BioXcel Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. BioXcel Therapeutics Inc 52 week low is $1.17 as of October 01, 2025.
What is BioXcel Therapeutics Inc stock price today?
BioXcel Therapeutics Inc stock price today is $2.56.
What was BioXcel Therapeutics Inc stock price yesterday?
BioXcel Therapeutics Inc stock price yesterday was $2.62.
What is the PE ratio of BioXcel Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. BioXcel Therapeutics Inc’s P/E ratio is -0.21.
What is the Price-to-Book ratio of BioXcel Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. BioXcel Therapeutics Inc P/B ratio is -0.1611.
What is the 50-day moving average of BioXcel Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. BioXcel Therapeutics Inc 50-day moving average is $3.47.
How many employess does BioXcel Therapeutics Inc has?